DOCSLIB.ORG

A Member of the Pyrin Family, IFI16, Is a Novel BRCA1-Associated Protein Involved in the P53-Mediated Apoptosis Pathway

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Member of the Pyrin Family, IFI16, Is a Novel BRCA1-Associated Protein Involved in the P53-Mediated Apoptosis Pathway Oncogene (2003) 22, 8931–8938 & 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway Jason A Aglipay1, Sam W Lee2, Shinya Okada1, Nobuko Fujiuchi1, Takao Ohtsuka2, Jennifer C Kwak2, Yi Wang3,4, Ricky W Johnstone5, Chuxia Deng6, Jun Qin3,4 and Toru Ouchi*,1 1The Derald H. Ruttenberg Cancer Center, The Mount Sinai School of Medicine, New York University, New York, NY, USA; 2Cancer Biology Program, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA; 3Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA; 4Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA; 5Trescowthick Research Laboratories, Peter MacCallum Cancer Institute, Victoria, Australia; 6Genetics of Development and Disease Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA We identified IFI16 as a BRCA1-associated protein C-terminal BRCT domains (Miki et al., 1994; Koonin involved in p53-mediated apoptosis. IFI16 contains the et al., 1996; Bork et al., 1997). Pyrin/PAAD/DAPIN domain, commonly found in cell Recently, mass-spectrometric analysis ofBRCA1- death-associated proteins. BRCA1 (aa 502–802) inter- interacting proteins revealed the presence of BRCA1- acted with the IFI16 Pyrin domain (aa 1–130). We found associated genome surveillance complex (BASC) (Wang that IFI16 was localized in the nucleoplasm and nucleoli. et al., 2000). This large complex includes ATM/ATR Clear nucleolar IFI16 localization was not observed in kinases, RAD51, MSH2, MSH6, MLH1, BLM and the HCC1937 BRCA1 mutant cells, but reintroduction of RAD50/Mre11/NBS complex, which are all involved in wild-type BRCA1 restored IFI16 nuclear relocalization homologous or nonhomologous recombination; coloca- following IR (ionizing radiation). Coexpression of IFI16 lization ofBRCA1 to these proteins has been demon- and BRCA1 enhanced DNA damage-induced apoptosis in strated by immunocytochemical analysis. A possible mouse embryonic fibroblasts from BRCA1 mutant mice role ofBRCA1 in the DNA repair machinery has also expressing wild-type p53, although mutant IFI16 deficient been shown by reintroduction ofwild-type or mutant in binding to BRCA1 did not induce apoptosis. Further- alleles ofBRCA1 into the HCC1937 breast cancer cell more, tetracycline-induced IFI16 collaborated in inducing line, which expresses truncated BRCA1 protein (Scully apoptosis when adenovirus p53 was expressed in DNA- et al., 1999). Thus, cells into which wild-type BRCA1 damaged p53-deficient EJ cells. These results indicate a has been reintroduced recovered resistance to DNA BRCA1-IFI16 role in p53-mediated transmission of DNA damage-induced cell death. Significantly, reintroduction damage signals and apoptosis. ofany patient-derived BRCA1 mutants examined has Oncogene (2003) 22, 8931–8938. doi:10.1038/sj.onc.1207057 failed to confer resistance to DNA damage on the recipient cells to the same degree as reintroduction of Keywords: BRCA1; IFI16; p53; apoptosis wild-type BRCA1, suggesting that the integrity provided by the complete structure ofthe BRCA1 protein is necessary for this activity. A significant body ofevidence also indicates that Introduction BRCA1 regulates cellular transcription factors such as p53, STAT1 and ZBRK1 (Ouchi et al., 1998; Zhang Germline mutations in the BRCA1 locus predispose et al., 1998; Ouchi et al., 2000; Zheng et al., 2000). women to early-onset, hereditary breast cancer (Miki Functional interaction between BRCA1 and p53 has et al., 1994). Mutations in BRCA1 have been found in been shown by murine experiments, where loss ofp53 approximately 90% offamilial breast and ovarian may lead to BRCA1-mutated breast cancer development cancers (reviewed by Alberg and Helzlsouer, 1997; and regulation ofapoptosis (Xu et al., 1999, 2001). A Nathanson et al., 2001). BRCA1 encodes a large, role ofBRCA1 in gene expression has been further multifunctional nuclear phosphoprotein of 1863 amino demonstrated by cDNA microarray analysis, in which acids containing the N-terminal RING finger and the tetracycline-regulatable BRCA1-induced GADD45 and expression ofseveral cellular genes (Harkin et al., 1999). IFI16 has been identified as a target ofinterferon (IFN) a and g and is a member ofthe HIN-200 family *Correspondence: T Ouchi, The Derald H Ruttenberg Cancer Center, (reviewed in Johnstone and Trapani, 1999). The Mount Sinai School ofMedicine, New York University, Box 1130, One Gustave L Levy Place, New York, NY 10029, USA; GAL4DBD-fused full-length IFI16 acts as a potent E-mail: [email protected] transcription repressor when positioned in proximity to Received 9 April 2003; revised 23 July 2003; accepted 31 July 2003 a promoter containing consensus GAL4DBD binding IFI16 is a novel BASC inducing p53-mediated cell death JA Aglipay et al 8932 sequences (Johnstone et al., 1998); however, it is unclear containing nuclear protein IFI16 (Trapani et al., 1992; whether IFI16 is involved in chromatin remodeling. Aravind et al., 2001), which coimmunoprecipitated with Each ofthe 200 amino acid repeat regions contains such BRCA1 when exposed to anti-BRCA1 antibody C20 transrepression activity independently, and the N- (Figure 1a). terminal can bind DNA (Dawson et al., 1995). It has Interaction ofBRCA1 and IFI16 was confirmed by been shown that IFI16 forms stable complexes with coimmunoprecipitation from normally growing HeLa cellular transcription factors such as SP1 and p53 cell nuclear extracts using a novel mouse monoclonal (reviewed in Johnstone and Trapani, 1999; Johnstone antibody (MAb21A8, ref. Okada and Ouchi, 2003) et al., 2000). More recently, the Pyrin domain, which is against the BRCA1 C-terminal and C20 polyclonal commonly found among cell death-associated proteins antibody. BRCA1 was immunoprecipitated from 300 mg such as Pyrin, ASC, and zebrafish caspase and is also ofnuclear extract and samples immunoblotted with referred to as the PAAD/DAPIN domain, has been mouse anti-IFI16 monoclonal antibody 1G7. Three major found in N-terminal IFI16, suggesting a role of IFI16 in IFI16 products were detected in the HeLa nuclear extract the apoptotic pathway (reviewed in Aravind et al., 2001; as a result ofalternative splicing ofthe IFI16 mRNA Fairbrother et al., 2001; Martinon et al., 2001; (Johnstone and Trapani, 1999). Both anti-BRCA1 Pawlowski et al., 2001; Staub et al., 2001). Presumably, antibodies coimmunoprecipitated endogenous IFI16 IFI16 regulates the activity ofcertain transcription (Figure 1b). We tested 12 anti-BRCA1 antibodies, which factors in the nucleus that are involved in the commit- all resulted in BRCA1 and IFI16 coimmunoprecipitation ment to cell death. (data not shown). Reciprocal coimmunoprecipitation In the present study, we further analysed the BRCA1- confirmed the interaction by immunoprecipitation of associated components identified through the mass IFI16 followed by BRCA1 immunoblot (Figure 1c). spectrometric analysis. We identified IFI16 as a pre- Densitometrically, B30% ofBRCA1 bound to B50% viously unknown member ofBASC, and found that ofIFI16. both IFI16 and BRCA1 colocalize in most ofthe cells Next, we mapped the BRCA1-IFI16 binding region examined by confocal laser microscopic analysis. IFI16 by means ofa GST-pulldown assay using 2 mg purified subcellular localization was transiently changed after GST-fusion protein and 500 mg HEK293T total cell DNA damage by IR, suggesting that IFI16 is involved lysate. These results showed that BRCA1 amino acids in the DNA damage pathway. Interestingly, IFI16 distribution, both in the nucleoplasm and nucleolar, is differentially regulated in normal human epithelial cells after DNA damage, but such regulation was abolished in the BRCA1-mutant breast cancer cell line. Most importantly, nucleolar accumulation ofIFI16 was restored by reexpression ofwild-type BRCA1 in BRCA1-mutant cells, strongly suggesting that IFI16 is involved in the BRCA1 pathway activated by DNA damage. Finally, studies using mouse embryonic fibro- blasts (MEFs) obtained from BRCA1-mutant mice with exon 11 deleted or tetracycline-regulatable IFI16 in EJ cells revealed proapoptosis activity ofIFI16 under conditions ofDNA damage, supporting a model of tumor suppression in which the BRCA1/IFI16 complex is involved in the p53-mediated cell death pathway. Results Identification of specific interaction between BRCA1 and IFI16 Our analysis ofproteins coimmunoprecipitating with Figure 1 Specific interaction between IFI16 and BRCA1. (a) BRCA1 identified a BRCA1-associated genome surveil- Schematic diagram ofIFI16 protein structure. The peptide lance complex (BASC) containing proteins ofthe DNA sequence obtained from mass spectrometric analysis of the BASC damage and DNA repair responses such as MSH2/ complex is also shown. (b, c) Coimmunoprecipitation ofendogen- ous BRCA1 and IFI16 from HeLa cell nuclear extract (300 mg). MSH6, MLH1/PMS2, ATM, BLM, replication factor C Total nuclear extract was 60 mg. (d, e) Identification ofthe regions (RFC) and the RAD50-MRE11-NBS1 complex as well where IFI16 and BRCA1 bind to one another. Samples were as p53 and STAT1 transcription factors (Ouchi et al., immunoblotted with the antibodies indicated. (f) HA-tagged full 1998; Zhang et al., 1998; Ouchi et al., 2000; Wang et al., length, but not N-terminal truncated, IFI16 coimmunoprecipitates 2000; Zheng et al.,
Load more

Recommended publications
  • Activated Peripheral-Blood-Derived Mononuclear Cells
    Transcription factor expression in lipopolysaccharide- activated peripheral-blood-derived mononuclear cells Jared C. Roach*†, Kelly D. Smith*‡, Katie L. Strobe*, Stephanie M. Nissen*, Christian D. Haudenschild§, Daixing Zhou§, Thomas J. Vasicek¶, G. A. Heldʈ, Gustavo A. Stolovitzkyʈ, Leroy E. Hood*†, and Alan Aderem* *Institute for Systems Biology, 1441 North 34th Street, Seattle, WA 98103; ‡Department of Pathology, University of Washington, Seattle, WA 98195; §Illumina, 25861 Industrial Boulevard, Hayward, CA 94545; ¶Medtronic, 710 Medtronic Parkway, Minneapolis, MN 55432; and ʈIBM Computational Biology Center, P.O. Box 218, Yorktown Heights, NY 10598 Contributed by Leroy E. Hood, August 21, 2007 (sent for review January 7, 2007) Transcription factors play a key role in integrating and modulating system. In this model system, we activated peripheral-blood-derived biological information. In this study, we comprehensively measured mononuclear cells, which can be loosely termed ‘‘macrophages,’’ the changing abundances of mRNAs over a time course of activation with lipopolysaccharide (LPS). We focused on the precise mea- of human peripheral-blood-derived mononuclear cells (‘‘macro- surement of mRNA concentrations. There is currently no high- phages’’) with lipopolysaccharide. Global and dynamic analysis of throughput technology that can precisely and sensitively measure all transcription factors in response to a physiological stimulus has yet to mRNAs in a system, although such technologies are likely to be be achieved in a human system, and our efforts significantly available in the near future. To demonstrate the potential utility of advanced this goal. We used multiple global high-throughput tech- such technologies, and to motivate their development and encour- nologies for measuring mRNA levels, including massively parallel age their use, we produced data from a combination of two distinct signature sequencing and GeneChip microarrays.
    [Show full text]
  • The Emerging Relevance of AIM2 in Liver Disease
    International Journal of Molecular Sciences Review The Emerging Relevance of AIM2 in Liver Disease Beatriz Lozano-Ruiz 1,2 and José M. González-Navajas 1,2,3,4,* 1 Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain; [email protected] 2 Department of Pharmacology, Paediatrics and Organic Chemistry, University Miguel Hernández (UMH), 03550 San Juan, Alicante, Spain 3 Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBERehd), Institute of Health Carlos III, 28029 Madrid, Spain 4 Institute of Research, Development and Innovation in Healthcare Biotechnology in Elche (IDiBE), University Miguel Hernández, 03202 Elche, Alicante, Spain * Correspondence: [email protected]; Tel.: +34-(965)-913-928 Received: 16 August 2020; Accepted: 4 September 2020; Published: 7 September 2020 Abstract: Absent in melanoma 2 (AIM2) is a cytosolic receptor that recognizes double-stranded DNA (dsDNA) and triggers the activation of the inflammasome cascade. Activation of the inflammasome results in the maturation of inflammatory cytokines, such as interleukin (IL)-1 β and IL-18, and a form of cell death known as pyroptosis. Owing to the conserved nature of its ligand, AIM2 is important during immune recognition of multiple pathogens. Additionally, AIM2 is also capable of recognizing host DNA during cellular damage or stress, thereby contributing to sterile inflammatory diseases. Inflammation, either in response to pathogens or due to sterile cellular damage, is at the center of the most prevalent and life-threatening liver diseases. Therefore, during the last 15 years, the study of inflammasome activation in the liver has emerged as a new research area in hepatology. Here, we discuss the known functions of AIM2 in the pathogenesis of different hepatic diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), hepatitis B, liver fibrosis, and hepatocellular carcinoma (HCC).
    [Show full text]
  • AIM2 Inflammasome Is Activated by Pharmacological Disruption Of
    AIM2 inflammasome is activated by pharmacological PNAS PLUS disruption of nuclear envelope integrity Antonia Di Miccoa,1, Gianluca Freraa,1,JérômeLugrina,1, Yvan Jamillouxa,b,Erh-TingHsuc,AubryTardivela, Aude De Gassarta, Léa Zaffalona, Bojan Bujisica, Stefanie Siegertd, Manfredo Quadronie, Petr Brozf, Thomas Henryb,ChristineA.Hrycynac,g, and Fabio Martinona,2 aDepartment of Biochemistry, University of Lausanne, Epalinges 1066, Switzerland; bINSERM, U1111, Center for Infectiology Research, Lyon 69007, France; cDepartment of Chemistry, Purdue University, West Lafayette, IN 47907-2084; dFlow Cytometry Facility, Ludwig Center for Cancer Research, University of Lausanne, Epalinges 1066, Switzerland; eProtein Analysis Facility, Center for Integrative Genomics, University of Lausanne, Lausanne 1015, Switzerland; fFocal Area Infection Biology, Biozentrum, University of Basel, 4056 Basel, Switzerland; and gPurdue Center for Cancer Research, Purdue University, West Lafayette, IN 47907-2084 Edited by Zhijian J. Chen, University of Texas Southwestern Medical Center/Howard Hughes Medical Institute, Dallas, TX, and approved June 21, 2016 (received for review February 12, 2016) Inflammasomes are critical sensors that convey cellular stress and and in vitro (19, 20). Beyond their broad use as anti-HIV drugs, pathogen presence to the immune system by activating inflamma- these molecules display beneficial HIV-unrelated functions, anti- tory caspases and cytokines such as IL-1β. The nature of endogenous malaria, antituberculosis, and antitumor properties (20). At the stress signals that activate inflammasomes remains unclear. Here cellular level, the HIV-PIs trigger an atypical ER stress-like we show that an inhibitor of the HIV aspartyl protease, Nelfinavir, transcriptional response that relies mostly on the activation of the triggers inflammasome formation and elicits an IL-1R–dependent integrated stress response (19, 21).
    [Show full text]
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants
    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
    [Show full text]
  • HHS Public Access Author Manuscript
    HHS Public Access Author manuscript Author Manuscript Author ManuscriptGenes Dis Author Manuscript. Author manuscript; Author Manuscript available in PMC 2015 March 24. Published in final edited form as: Genes Dis. 2015 March ; 2(1): 46–56. doi:10.1016/j.gendis.2014.10.003. The roles of interferon-inducible p200 family members IFI16 and p204 in innate immune responses, cell differentiation and proliferation Hua Zhaoa,b, Elena Gonzalezgugela, Lei Chengb, Brendon Richbourgha, Lin Nieb,*, and Chuanju Liua,c aDepartment of Orthopaedic Surgery, New York University School of Medicine, New York, NY 10003, United States bDepartment of Spine Surgery, Qilu Hospital of Shandong University, Jinan, 250014, China cDepartment of Cell Biology, New York University School of Medicine, New York, NY 10016, United States Abstract p204 is a member of the interferon-inducible p200 family proteins in mice. The p200 family has been reported to be multifunctional regulators of cell proliferation, differentiation, apoptosis and senescence. Interferon-inducible protein 16 (IFI16) is regarded as the human ortholog of p204 in several studies. This is possibly due to the similarity of their structures. However the consistency of their functions is still elusive. Currently, an emerging focus has been placed upon the role of the p200 proteins as sensors for microbial DNA in innate immune responses and provides new insights into infections as well as autoimmune diseases. This review specially focuses on IFI16 and p204, the member of p200 family in human and murine respectively, and their pathophysiological roles in innate immune responses, cell differentiation and proliferation. Keywords DNA sensor; IFI16; Innate immune; response; Multifunctional; regulator; p204 Introduction p204 is a multifunctional interferon-inducible murine protein in the p200 family (also known as PYHIN or HIN-200 proteins).
    [Show full text]
  • Ten Commandments for a Good Scientist
    Unravelling the mechanism of differential biological responses induced by food-borne xeno- and phyto-estrogenic compounds Ana María Sotoca Covaleda Wageningen 2010 Thesis committee Thesis supervisors Prof. dr. ir. Ivonne M.C.M. Rietjens Professor of Toxicology Wageningen University Prof. dr. Albertinka J. Murk Personal chair at the sub-department of Toxicology Wageningen University Thesis co-supervisor Dr. ir. Jacques J.M. Vervoort Associate professor at the Laboratory of Biochemistry Wageningen University Other members Prof. dr. Michael R. Muller, Wageningen University Prof. dr. ir. Huub F.J. Savelkoul, Wageningen University Prof. dr. Everardus J. van Zoelen, Radboud University Nijmegen Dr. ir. Toine F.H. Bovee, RIKILT, Wageningen This research was conducted under the auspices of the Graduate School VLAG Unravelling the mechanism of differential biological responses induced by food-borne xeno- and phyto-estrogenic compounds Ana María Sotoca Covaleda Thesis submitted in fulfillment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. dr. M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Tuesday 14 September 2010 at 4 p.m. in the Aula Unravelling the mechanism of differential biological responses induced by food-borne xeno- and phyto-estrogenic compounds. Ana María Sotoca Covaleda Thesis Wageningen University, Wageningen, The Netherlands, 2010, With references, and with summary in Dutch. ISBN: 978-90-8585-707-5 “Caminante no hay camino, se hace camino al andar. Al andar se hace camino, y al volver la vista atrás se ve la senda que nunca se ha de volver a pisar” - Antonio Machado – A mi madre.
    [Show full text]
  • Interleukin-18 in Health and Disease
    International Journal of Molecular Sciences Review Interleukin-18 in Health and Disease Koubun Yasuda 1 , Kenji Nakanishi 1,* and Hiroko Tsutsui 2 1 Department of Immunology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan; [email protected] 2 Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-798-45-6573 Received: 21 December 2018; Accepted: 29 January 2019; Published: 2 February 2019 Abstract: Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. Therefore, IL-12 is a commitment factor that induces the development of Th1 cells. In contrast, IL-18 is a proinflammatory cytokine that facilitates type 1 responses. However, IL-18 without IL-12 but with IL-2, stimulates NK cells, CD4+ NKT cells, and established Th1 cells, to produce IL-3, IL-9, and IL-13. Furthermore, together with IL-3, IL-18 stimulates mast cells and basophils to produce IL-4, IL-13, and chemical mediators such as histamine. Therefore, IL-18 is a cytokine that stimulates various cell types and has pleiotropic functions. IL-18 is a member of the IL-1 family of cytokines. IL-18 demonstrates a unique function by binding to a specific receptor expressed on various types of cells.
    [Show full text]
  • Complementary Regulation of Caspase-1 and IL-1Β Reveals Additional Mechanisms of Dampened Inflammation in Bats
    Complementary regulation of caspase-1 and IL-1β reveals additional mechanisms of dampened inflammation in bats Geraldine Goha,1, Matae Ahna,1, Feng Zhua, Lim Beng Leea, Dahai Luob,c, Aaron T. Irvinga,d,2, and Lin-Fa Wanga,e,2 aProgramme in Emerging Infectious Diseases, Duke–National University of Singapore Medical School, 169857, Singapore; bLee Kong Chian School of Medicine, Nanyang Technological University, 636921, Singapore; cNTU Institute of Structural Biology, Nanyang Technological University, 636921, Singapore; dZhejiang University–University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University International Campus, Haining, 314400, China; and eSinghealth Duke–NUS Global Health Institute, 169857, Singapore Edited by Vishva M. Dixit, Genentech, San Francisco, CA, and approved September 14, 2020 (received for review February 21, 2020) Bats have emerged as unique mammalian vectors harboring a experimental confirmation is rare. We recently demonstrated diverse range of highly lethal zoonotic viruses with minimal that NLRP3 is dampened in bats as a result of loss-of-function clinical disease. Despite having sustained complete genomic loss bat-specific isoforms and impaired transcriptional priming (9). of AIM2, regulation of the downstream inflammasome response in The stimulator of IFN genes (STING), a key adaptor to the bats is unknown. AIM2 sensing of cytoplasmic DNA triggers ASC DNA-sensing cGAS protein, is also exclusively mutated at S358 aggregation and recruits caspase-1, the central inflammasome ef- in bats, resulting in a reduced IFN response to HSV1 (10). We fector enzyme, triggering cleavage of cytokines such as IL-1β and previously reported a complete absence of Absent in melanoma inducing GSDMD-mediated pyroptotic cell death.
    [Show full text]
  • IFI16 and Cgas Cooperate in the Activation of STING During DNA Sensing in Human Keratinocytes
    ARTICLE Received 15 Dec 2015 | Accepted 22 Dec 2016 | Published 13 Feb 2017 DOI: 10.1038/ncomms14392 OPEN IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes Jessica F. Almine1,2,*, Craig A.J. O’Hare1,2,*, Gillian Dunphy1,2, Ismar R. Haga3, Rangeetha J. Naik1, Abdelmadjid Atrih4, Dympna J. Connolly5, Jordan Taylor1, Ian R. Kelsall1, Andrew G. Bowie5, Philippa M. Beard3,6 & Leonie Unterholzner1,2 Many human cells can sense the presence of exogenous DNA during infection though the cytosolic DNA receptor cyclic GMP-AMP synthase (cGAS), which produces the second messenger cyclic GMP-AMP (cGAMP). Other putative DNA receptors have been described, but whether their functions are redundant, tissue-specific or integrated in the cGAS-cGAMP pathway is unclear. Here we show that interferon-g inducible protein 16 (IFI16) cooperates with cGAS during DNA sensing in human keratinocytes, as both cGAS and IFI16 are required for the full activation of an innate immune response to exogenous DNA and DNA viruses. IFI16 is also required for the cGAMP-induced activation of STING, and interacts with STING to promote STING phosphorylation and translocation. We propose that the two DNA sensors IFI16 and cGAS cooperate to prevent the spurious activation of the type I interferon response. 1 Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. 2 Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK. 3 The Pirbright Institute, Pirbright, Surrey GU24 0NF, UK. 4 Fingerprints Proteomics Facility, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
    [Show full text]
  • A Pathologic Link Between Wilms Tumor Suppressor Gene, WT1, And
    Volume 10 Number 1 January 2008 pp. 69–78 69 www.neoplasia.com RESEARCH ARTICLE † Marianne K.-H. Kim*, Jacqueline M. Mason , A Pathologic Link between Wilms ‡ § Chi-Ming Li , Windy Berkofsky-Fessler , ∥ WT1 Le Jiang , Divaker Choubey¶, Paul E. Grundy#, Tumor Suppressor Gene, , ∥ and IFI161,2 Benjamin Tycko and Jonathan D. Licht* *Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA; †The Campbell Family Institute for Breast Cancer Research at the Ontario, Cancer Institute, Ontario, Canada; ‡Translational Medicine, Amgen, Thousand Oaks, CA, USA; §Section of Bioinformatics, Genetics and Genomics, Hoffmann-La Roche Inc, Nutley, NJ, USA; ∥Institute for Cancer Genetics and Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA; ¶University of Cincinnati, Cincinnati, OH, USA; #University of Alberta, Alberta, Canada Abstract The Wilms tumor gene (WT1) is mutated or deleted in patients with heredofamilial syndromes associated with the development of Wilms tumors, but is infrequently mutated in sporadic Wilms tumors. By comparing the micro- array profiles of syndromic versus sporadic Wilms tumors and WT1-inducible Saos-2 osteosarcoma cells, we iden- tified interferon-inducible protein 16 (IFI16), a transcriptional modulator, as a differentially expressed gene and a candidate WT1 target gene. WT1 induction in Saos-2 osteosarcoma cells led to strong induction of IFI16 expression and its promoter activity was responsive to the WT1 protein. Immunohistochemical analysis showed that IFI16 and WT1 colocalized in WT1-replete Wilms tumors, but not in normal human midgestation fetal kidneys, suggesting that the ability of WT1 to regulate IFI16 in tumors represented an aberrant pathologic relationship.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • The Tumor Suppressor HHEX Inhibits Axon Growth When Prematurely Expressed in Developing Central Nervous System Neurons
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by epublications@Marquette Marquette University e-Publications@Marquette Biological Sciences Faculty Research and Biological Sciences, Department of Publications 9-1-2015 The umorT Suppressor HHEX Inhibits Axon Growth when Prematurely Expressed in Developing Central Nervous System Neurons Matthew .T Simpson Marquette University Ishwariya Venkatesh Marquette University Ben L. Callif Marquette University Laura K. Thiel Marquette University Denise M. Coley Marquette University See next page for additional authors Accepted version. Molecular and Cellular Neuroscience, Vol 68 )September 2015): 272-283. DOI. © 2015 Elsevier Inc. Used with permission. NOTICE: this is the author’s version of a work that was accepted for publication in Molecular and Cellular Neuroscience. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Molecular and Cellular Neuroscience, Vol 68 )September 2015): 272-283. DOI. Authors Matthew T. Simpson, Ishwariya Venkatesh, Ben L. Callif, Laura K. Thiel, Denise M. Coley, Kristen N. Winsor, Zimei Wang, Audra A. Kramer, Jessica K. Lerch, and Murray G. Blackmore This article is available at e-Publications@Marquette: https://epublications.marquette.edu/bio_fac/515 NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be accessed by following the link in the citation at the bottom of the page. The Tumor Suppressor HHEX Inhibits Axon Growth When Prematurely Expressed in Developing Central Nervous System Neurons Matthew T.
    [Show full text]